Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
Speakers Miranda Fisher, PhD and Amica Simmons-Yon, PharmD, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)